FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

19,481 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 18800 - 19000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.556CABG_Clinical Grouping Condition_ICD10PCSactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.557CABG_Clinical Grouping Condition_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.351Coronary Artery Disease (CAD)_ICD9active2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.352Coronary Artery Disease (CAD)_ICD10PCSactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.353Coronary Artery Disease (CAD)_ICD10CMactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.354Coronary Artery Disease (CAD)_CPTactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.355Coronary Artery Disease (CAD)_HCPCSactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.356Coronary Artery Disease (CAD)_LOINCactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.357Coronary Artery Disease (CAD)_SNOMEDactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.358Coronary Artery Disease (CAD)_CUI_UMLSactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.245Chronic Heart Failure (CHF)_ICD9active2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.246Chronic Heart Failure (CHF)_ICD10active2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.258Heart Failure (CHF)_ICD9active2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.259Heart Failure (CHF)_ICD10active2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.260Heart Failure (CHF)_SNOMEDactive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.261Heart Failure (CHF)_HCPCSactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.262Heart Failure (CHF)_LOINCactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.263Heart Failure (CHF)_CPTactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.264Heart Failure (CHF)_RxNormactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.585COPD_Clinical_Grouping_Condition_ICD9active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.586COPD_Clinical_Grouping_Condition_ICD10active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.587COPD_Clinical_Grouping_Condition_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.345COVID19 Vaccine_CPTactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.346COVID19 Vaccine_HCPCSactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.348COVID19 Vaccine_RxNormactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.349COVID19 Vaccine_CVXactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.291CT Colonography_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.292CT Colonography_LOINCactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.294CT Colonography_Event_Groupingactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.388Cardiology _Taxonomyactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.333Cervical Cytology_HD_CPTactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.334Cervical Cytology_HD_HCPCSactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.335Cervical Cytology_HD_LOINCactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.336Cervical Cytology_HD_SNOMEDactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.373Cirrhosis_SNOMEDactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.374Cirrhosis_ICD10active2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.286Colectomy_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.288Colectomy_ICD9active2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.290Colectomy_Event_Groupingactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.305Colonoscopy_CPTactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.306Colonoscopy_HCPCSactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.307Colonoscopy_ICD9active2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.308Colonoscopy_SNOMEDactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.309Colonoscopy_Event_Groupingactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.315Colorectal Cancer_HD_ICD10active2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.316Colorectal Cancer_HD_ICD9active2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.317Colorectal Cancer_HD_SNOMEDactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.607Diastolic Blood Pressure_Compliant_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.608Systolic Blood Pressure_Compliant_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.602Contrast induced nephropathy_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.603Contrast induced nephropathy_ICD10active2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.604Contrast induced nephropathy_Groupingactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.543Depression_Clinical Grouping Condition_CPTactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.544Depression_Clinical Grouping Condition_HCPCSactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.545Depression_Clinical Grouping Condition_ICD10active2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.546Depression_Clinical Grouping Condition_ICD9active2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.547Depression_Clinical Grouping Condition_LOINCactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.548Depression_Clinical Grouping Condition_SNOMEDactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.165Optometrist and Ophthalmologist Taxonomy HD Taxonomyactive2023-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.164Diabetic Retinal Screening HD CPT for Tax Pairactive2023-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.56Diabetic Retinal Screening HD CPTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.582Diastolic Less than 90_HD_Clinical Grouping Event_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.167End Stage Renal Disease (ESRD)_HD_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.168End Stage Renal Disease (ESRD)_HD_ICD9active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.169End Stage Renal Disease (ESRD)_HD_ICD10active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.170End Stage Renal Disease (ESRD)_HD_HCPCSactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.171End Stage Renal Disease (ESRD)_HD_LOINCactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.565Essential HTN_HD_Clinical Grouping Condition_ICD10active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.566Essential HTN_HD_Clinical Grouping Condition_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.379Estrogen Agonists Medications_RXNORMactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.299FIT DNA Test_Lab_Groupingactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.295FIT DNA_LOINCactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.296FIT DNA_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.297FIT DNA_HCPCSactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.298FIT DNA_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.314FOBT Lab Test_Lab_Groupingactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.310FOBT Lab_CPTactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.311FOBT Lab_HCPCSactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.312FOBT Lab_LOINCactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.313FOBT Lab_SNOMEDactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.244Fasting Blood Glucose_Lab_Groupingactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.401First Trimester_ICD10active2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.402First Trimester_SNOMEDactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.403First Trimester_LOINCactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.404First Trimester_CPTactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.405First Trimester_UMLS CUIactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.205Bone Marrow Transplant CN_HD_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.206Bone Marrow Transplant CN_HD_ICD10active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.208Immunocompromising Conditions CN_HD_ICD9active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.209Immunocompromising Conditions CN_HD_ICD10PCSactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.210Immunocompromising Conditions CN_HD_ICD10CMactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.212Immunocompromising Conditions CN_HD_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.213Cerebrospinal Fluid Leak CN_HD_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.214Cerebrospinal Fluid Leak CN_HD_ICD10active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.216Anatomic or Functional Asplenia CN_HD_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.217Anatomic or Functional Asplenia CN_HD_ICD9active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.218Anatomic or Functional Asplenia CN_HD_ICD10active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.220Sickle cell Anemia and HB S Disease CN_HD_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.221Sickle cell Anemia and HB S Disease CN_HD_ICD10active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.224Pneumococcal Vaccine CN_HD_HCPCSactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.225Pneumococcal Vaccine CN_HD_CVXactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.226Pneumococcal Vaccine CN_HD_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.233Cochlear Implant CN_HD_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.234Cochlear Implant CN_HD_ICD10active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.235Cochlear Implant CN_HD_HCPCSactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.236Cochlear Implant CN_HD_CPTactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.238Chemotherapy CN_HD_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.239Chemotherapy CN_HD_ICD10active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.240Chemotherapy CN_HD_CPTactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.284HDL_LOINCactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.285HDL_Lab_Groupingactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.579HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.328High Risk HPV Test_HD_CPTactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.329High Risk HPV Test_HD_HCPCSactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.330High Risk HPV Test_HD_LOINCactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.331High Risk HPV Test_HD_SNOMEDactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.332High Risk HPV Test_HD_Groupingactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.337Cervical Cytology_HD_Groupingactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.323Hysterectomy With No Residual Cervix_HD_CPTactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.324Hysterectomy With No Residual Cervix_HD_ICD10active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.325Hysterectomy With No Residual Cervix_HD_ICD9active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.326Hysterectomy With No Residual Cervix_HD_SNOMEDactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.327Hysterectomy With No Residual Cervix_HD_Groupingactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.376IVF_SNOMEDactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.377IVF_HCPCSactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.228Influenza Vaccine CN_HD_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.229Influenza Vaccine CN_HD_HCPCSactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.230Influenza Vaccine CN_HD_CVXactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.231Influenza Vaccine CN_HD_CPTactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.367Ischemic Vascular Disease (IVD)_SNOMEDactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.368Ischemic Vascular Disease (IVD)_ICD10active2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.276LDL_SNOMEDactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.280LDL_Lab_Groupingactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.194Lipid Panel_Event_SNOMEDactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.195Lipid Panel_Event_HCPCSactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.196Lipid Panel_Event_LOINCactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.197Lipid Panel_Event_CPTactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.517Lupus_Clinical_Condition_ICD10active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.519Lupus_Clinical_Condition_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.550MI (Myocardial Infarction)_Clinical Grouping Condition_ICD9active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.551MI (Myocardial Infarction)_Clinical Grouping Condition_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.552MI (Myocardial Infarction)_Clinical Grouping Condition_ICD10active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.370Muscular Pain and Disease_SNOMEDactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.371Muscular Pain and Disease_ICD10active2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.472OGTT_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.473OGTT_ICD10active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.475OGTT_LOINCactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.476OGTT_Groupingactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.386Obesity_Condition_UMLSactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.414Obesity_Condition_SNOMEDactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.415Obesity_Condition_ICD10active2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.416Obesity_Condition_ICD9active2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.427Obesity_Condition_LOINCactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.364Other Revascularization_SNOMEDactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.365Other Revascularization_CPTactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.559PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.560PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_HCPCSactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.561PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD10PCSactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.562PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD9PCSactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.563PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.223Pneumococcal Vaccine CN_HD_SNOMEDactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.387Podiatry_Taxonomyactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.589Polypharmacy_Clinical_Grouping_Condition_ICD10active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.590Polypharmacy_Clinical_Grouping_Condition_ICD9active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.591Polypharmacy_Clinical_Grouping_Condition_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.592Polypharmacy_Clinical_Grouping_Condition_LOINCactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.525Postpartum_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.526Postpartum_HCPCSactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.527Postpartum_ICD10active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.528Postpartum_ICD9CMactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.529Postpartum_LOINCactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.530Postpartum_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.418Pre_Hypertension (Pre_HTN)_ICD10active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.419Pre_Hypertension (Pre_HTN)_ICD9active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.420Pre_Hypertension (Pre_HTN)_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.502Prediabetes_Clinical Grouping Condition_ICD10active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.503Prediabetes_Clinical Grouping Condition_SNOMEDactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.469Pregnancy Due Date_LOINCactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.254Pregnancy Loss_HD_SNOMEDactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.255Pregnancy Loss_HD_ICD10active2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.479Prostate Cancer Screening_HD_ICD9active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.482Prostate Cancer Screening_HD_Groupingactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.484Prostate Dysplasia_ICD10active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.486Prostate Dysplasia_Groupingactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.487Prostectomy_ICD10active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.488Prostectomy_CPTactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.490Prostectomy_Groupingactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.494PSA Testing _LOINCactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.495PSA Testing_Groupingactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.501Abnormal PSA Testing _SNOMEDactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.463Second Trimester_ICD10active2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.464Second Trimester_SNOMEDactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.470Second Trimester_LOINCactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.477Second Trimester_CPTactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.300Sigmoidoscopy_CPTactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.302Sigmoidoscopy_ICD9active2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.303Sigmoidoscopy_SNOMEDactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.304Sigmoidoscopy_Event_Groupingactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.363Statin Use_RxNormactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.581Systolic Less than 140_HD_Clinical Grouping Event_CPTactive2025-02hl7